ARENAX*24 is an artemisinin-based combination therapy (ACT) presented in a 24-tablet pack. It contains a fixed-dose combination of antimalarial medicines commonly used in the treatment of uncomplicated malaria caused by Plasmodium falciparum and other susceptible species. The combination works by rapidly reducing the number of malaria parasites in the bloodstream and helping to prevent recurrence when taken as directed. The 24-tablet presentation is typically formulated for adults and older children according to weight-based dosing guidelines.

Active Ingredient(s) / Generic Name

• Artemether 20 mg

• Lumefantrine 120 mg

• Generic Names: Artemether and Lumefantrine

Brand Name / Manufacturer / Marketer

• Brand Name: ARENAX*24

• Manufacturer/Marketer: (Refer to product packaging for specific manufacturer details)

Indications / Uses

• Treatment of uncomplicated malaria infections caused by Plasmodium falciparum

• Management of acute symptomatic malaria confirmed or suspected to be due to susceptible strains

This medicine is usually taken as a full course over three days according to prescribed dosing schedules. Completing the full treatment course is important to ensure effective parasite clearance.

Storage Instructions

• Store below 30°C in a dry place

• Keep in the original packaging to protect from moisture and light

• Keep out of reach and sight of children

Disclaimer
This product description is provided for informational purposes only. ARENAX*24 should be used under the supervision of a qualified healthcare professional. Always follow your doctor’s or pharmacist’s instructions and read the patient information leaflet before use. Do not use this medicine without proper medical guidance.